EP3110843
Samsetningarmeðferðir með AND-CD38 mótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.2.2015EP published:
11.9.2019EP application number:
15755187.0
EP translation filed:
8.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
24.2.2035Expiry date:
24.2.2026Next due date:
28.2.2026
Title:
COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES
Timeline
Today
25.2.2015EP application
11.9.2019EP Publication
8.10.2019Translation submitted
15.11.2019Registration published
24.2.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, 19044, Horsham, PA, US
Inventor
Name:
DOSHI, ParulAddress:
Spring House,Pennsylvania, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461946002 PDate:
28.2.2014Country:
US
Number:
201462006386 PDate:
2.6.2014Country:
US
Classification
Categories:
A61K 31/4745, A61K 39/395, A61K 31/573, A61K 31/65, A61K 31/675, A61P 35/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.1.2020
Expires: 24.2.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.1.2021
Expires: 24.2.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.1.2022
Expires: 24.2.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2023
Expires: 24.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2023
Expires: 24.2.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.1.2023
Expires: 24.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.1.2024
Expires: 24.2.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.1.2025
Expires: 24.2.2026
Payer: Árnason Faktor ehf.